Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 11/20 | 0.46 |
| ▸ | MAPT | P10636 | 8/20 | 0.46 |
| ▸ | MEN1 | O00255 | 7/20 | 0.46 |
| ▸ | POLB | P06746 | 3/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 11/20 | 0.42 |
| ▸ | HPGD | P15428 | 8/20 | 0.42 |
| ▸ | HTT | P42858 | 4/20 | 0.42 |
| ▸ | USP2 | O75604 | 4/20 | 0.39 |
| ▸ | KEAP1 | Q14145 | 3/20 | 0.39 |
| ▸ | NFE2L2 | Q16236 | 3/20 | 0.39 |
| ▸ | VDR | P11473 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | XBP1 | P17861 | 2/20 | 0.35 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17185507 | 0.86 | KMT2A (0.45) | KMT2AMAPTMEN1POLBL3MBTL1 | |
| SCHEMBL18069174 | 0.82 | KMT2A (0.41) | KMT2AMAPTMEN1POLBL3MBTL1 | |
| SCHEMBL15705346 | 0.81 | KMT2A (0.40) | KMT2AMAPTMEN1POLBL3MBTL1 | |
| SCHEMBL18069175 | 0.80 | TDP1 (0.40) | KMT2AMAPTMEN1POLBL3MBTL1 | |
| SCHEMBL17195063 | 0.79 | KCNH2 (0.40) | KMT2AMAPTMEN1POLBL3MBTL1 | |
| SCHEMBL17195065 | 0.79 | KMT2A (0.41) | KMT2AMAPTMEN1POLBL3MBTL1 | |
| SCHEMBL17185506 | 0.78 | MAPT (0.54) | KMT2AMAPTMEN1POLBL3MBTL1 | |
| SCHEMBL18069205 | 0.78 | KMT2A (0.42) | KMT2AMAPTMEN1POLBL3MBTL1 | |
| SCHEMBL18069201 | 0.78 | KMT2A (0.42) | KMT2AMAPTMEN1POLBL3MBTL1 | |
| SCHEMBL18069183 | 0.78 | TDP1 (0.39) | KMT2AMAPTMEN1POLBL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9709886-B2 | Sulfonic acid derivative compounds as photoacid generators in resist applications | Heraeus Precious Metals North America Daychem LLC (US) | 2017-07-18 | — | — | US | disclosed |
| US-20170003587-A1 | SULFONIC ACID DERIVATIVE COMPOUNDS AS PHOTOACID GENERATORS IN RESIST APPLICATIONS | HERAEUS EPURIO LLC | 2017-01-05 | — | — | US | disclosed |
| US-9477150-B2 | Sulfonic acid derivative compounds as photoacid generators in resist applications | Heraeus Precious Metals North America Daychem LLC (US) | 2016-10-25 | — | — | US | disclosed |
| US-20160266487-A1 | SULFONIC ACID DERIVATIVE COMPOUNDS AS PHOTOACID GENERATORS IN RESIST APPLICATIONS | HERAEUS EPURIO LLC | 2016-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160266487-A1 | SULFONIC ACID DERIVATIVE COMPOUNDS AS PHOTOACID GENERATORS IN RESIST APPLICATIONS | ALAD, MPST, ASIC1 | KMT2A 1020/4885MAPT 3437/4885MEN1 1317/4885 |
| US-20170003587-A1 | SULFONIC ACID DERIVATIVE COMPOUNDS AS PHOTOACID GENERATORS IN RESIST APPLICATIONS | ALAD, MPST, ASIC1 | KMT2A 1020/4885MAPT 3437/4885MEN1 1317/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.